Growth Metrics

BeOne Medicines (ONC) EBT Margin (2015 - 2026)

BeOne Medicines (ONC) reported EBT Margin of 17.13% for Q1 2026, up 1526.0% year-over-year from 1.05% in Q1 2025, and up 71.94% on a QoQ basis from 9.96% in Q4 2025.

BeOne Medicines (ONC) has 12 years of EBT Margin data on file, last reported at 17.13% in Q1 2026.

  • Quarterly EBT Margin rose 1526.0% year-over-year to 17.13% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.42% (up 1785.0% YoY) and the FY2025 annual result came in at 7.8%, up 2179.0% from the prior year.
  • EBT Margin climbed to 17.13% in Q1 2026 per ONC's latest filing, from 9.96% in the prior quarter.
  • Across five years, EBT Margin topped out at 29.35% in Q3 2023 and bottomed at 163.24% in Q2 2022.
  • The 5-year median for EBT Margin is 11.4% (2024), against an average of 43.14%.
  • The widest annual swing landed in 2022, when EBT Margin plunged 14759 bps; it then soared 17156 bps in 2023.
  • Tracing ONC's EBT Margin over 5 years: stood at 113.38% in 2022, then jumped by 51 bps to 55.29% in 2023, then jumped by 86 bps to 7.57% in 2024, then surged by 232 bps to 9.96% in 2025, then surged by 72 bps to 17.13% in 2026.
  • Per Business Quant, the three latest ONC EBT Margin figures stand at 17.13% (Q1 2026), 9.96% (Q4 2025), and 10.42% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 41.95%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 23.05%
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 18.99%
10 BeOne Medicines - - 1.35 Bn 17.13%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 17.13%
Dec 31, 2025 9.96%
Sep 30, 2025 10.42%
Jun 30, 2025 7.57%
Mar 31, 2025 1.87%
Dec 31, 2024 -7.57%
Sep 30, 2024 -9.81%
Jun 30, 2024 -11.40%
Mar 31, 2024 -32.39%
Dec 31, 2023 -55.29%
Sep 30, 2023 29.35%
Jun 30, 2023 -61.73%
Mar 31, 2023 -75.24%
Dec 31, 2022 -113.38%
Sep 30, 2022 -142.21%
Jun 30, 2022 -163.24%
Mar 31, 2022 -137.38%
Dec 31, 2021 -283.22%
Sep 30, 2021 -209.78%
Jun 30, 2021 -320.40%
Mar 31, 2021 10.21%
Dec 31, 2020 -481.49%
Sep 30, 2020 -477.65%
Jun 30, 2020 -514.65%
Mar 31, 2020 -698.03%
Dec 31, 2019 -668.52%
Sep 30, 2019 -622.00%
Jun 30, 2019 -55.88%
Mar 31, 2019 -215.27%
Dec 31, 2018 -469.16%
Sep 30, 2018 -267.45%
Jun 30, 2018 -305.06%
Mar 31, 2018 -333.48%
Dec 31, 2017 -519.23%
Sep 30, 2017 51.87%
Jun 30, 2016 -6,104.07%
Mar 31, 2016 -3,243.28%
Dec 31, 2015 525.96%
Sep 30, 2015 -1,014.42%
Jun 30, 2015 -408.77%
Mar 31, 2015 -740.54%